Literature DB >> 19626188

The importance of genetic testing in the clinical management of patients with Marfan syndrome and related disorders.

Mine Arslan-Kirchner1, Yskert von Kodolitsch, Jörg Schmidtke.   

Abstract

INTRODUCTION: Marfan syndrome and Marfan-related syndromes are part of a broad and overlapping spectrum of diseases that were originally defined on clinical grounds alone. They have in common a dramatically increased risk of life-threatening dissecting aortic aneurysms, which must be prevented by elective aortic replacement.
METHODS: Selective review of the literature supplemented by own clinical experience.
RESULTS: Marfan syndrome and Marfan-related syndromes are phenotypically highly variable. The full-blown clinical picture is not always present, and particular symptoms can be missing altogether. Accordingly, it is often very difficult to diagnose a specific syndrome in the individual patient. In many cases, only a combination of genetic tests and clinical assessment can settle the differential diagnosis, thus enabling better prognostication and better planning of preventive measures. DISCUSSION: The diagnosis and treatment of individual patients with Marfan syndrome and Marfan-related syndromes requires an interdisciplinary approach. This can only be achieved through a coordination of medical care with centralized record-keeping of all diagnostic findings.

Entities:  

Keywords:  Marfan syndrome; aneurysm; aortic syndrome; genetic testing; mitral valve prolaps; molecular medicine

Year:  2008        PMID: 19626188      PMCID: PMC2696906          DOI: 10.3238/arztebl.2008.0483

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  17 in total

1.  TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome.

Authors:  Krishna Kumar Singh; Kathrin Rommel; Anjali Mishra; Matthias Karck; Axel Haverich; Jörg Schmidtke; Mine Arslan-Kirchner
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

2.  Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections.

Authors:  Dong-Chuan Guo; Hariyadarshi Pannu; Van Tran-Fadulu; Christina L Papke; Robert K Yu; Nili Avidan; Scott Bourgeois; Anthony L Estrera; Hazim J Safi; Elizabeth Sparks; David Amor; Lesley Ades; Vivienne McConnell; Colin E Willoughby; Dianne Abuelo; Marcia Willing; Richard A Lewis; Dong H Kim; Steve Scherer; Poyee P Tung; Chul Ahn; L Maximilian Buja; C S Raman; Sanjay S Shete; Dianna M Milewicz
Journal:  Nat Genet       Date:  2007-11-11       Impact factor: 38.330

Review 3.  Marfan syndrome: an update of genetics, medical and surgical management.

Authors:  Yskert von Kodolitsch; Peter N Robinson
Journal:  Heart       Date:  2007-06       Impact factor: 5.994

Review 4.  [Lysis therapy in aortic dissection: by hypertrophic cardiomyopathy simulated myocardial infarct].

Authors:  Y Kodolitsch; P Kühnel; G Kreymann; C A Nienaber
Journal:  Z Kardiol       Date:  1998-02

5.  Revised diagnostic criteria for the Marfan syndrome.

Authors:  A De Paepe; R B Devereux; H C Dietz; R C Hennekam; R E Pyeritz
Journal:  Am J Med Genet       Date:  1996-04-24

6.  Aneurysm syndromes caused by mutations in the TGF-beta receptor.

Authors:  Bart L Loeys; Ulrike Schwarze; Tammy Holm; Bert L Callewaert; George H Thomas; Hariyadarshi Pannu; Julie F De Backer; Gretchen L Oswald; Sofie Symoens; Sylvie Manouvrier; Amy E Roberts; Francesca Faravelli; M Alba Greco; Reed E Pyeritz; Dianna M Milewicz; Paul J Coucke; Duke E Cameron; Alan C Braverman; Peter H Byers; Anne M De Paepe; Harry C Dietz
Journal:  N Engl J Med       Date:  2006-08-24       Impact factor: 91.245

7.  Utility of molecular analyses in the exploration of extreme intrafamilial variability in the Marfan syndrome.

Authors:  J De Backer; B Loeys; B Leroy; P Coucke; H Dietz; A De Paepe
Journal:  Clin Genet       Date:  2007-09       Impact factor: 4.438

8.  Life expectancy in the Marfan syndrome.

Authors:  D I Silverman; K J Burton; J Gray; M S Bosner; N T Kouchoukos; M J Roman; M Boxer; R B Devereux; P Tsipouras
Journal:  Am J Cardiol       Date:  1995-01-15       Impact factor: 2.778

9.  Diagnosis and management of Marfan syndrome.

Authors:  Yskert von Kodolitsch; Meike Rybczynski; Christian Detter; Peter N Robinson
Journal:  Future Cardiol       Date:  2008-01

Review 10.  Therapy of Marfan syndrome.

Authors:  Daniel P Judge; Harry C Dietz
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

View more
  6 in total

Review 1.  Aneurysms of the ascending aorta.

Authors:  Daniel Lavall; Hans-Joachim Schäfers; Michael Böhm; Ulrich Laufs
Journal:  Dtsch Arztebl Int       Date:  2012-03-30       Impact factor: 5.594

2.  Management of patients with aortic dissection.

Authors:  Ernst Weigang; Christoph A Nienaber; Tim C Rehders; Hüseyin Ince; Christian-Friedrich Vahl; Friedhelm Beyersdorf
Journal:  Dtsch Arztebl Int       Date:  2008-09-19       Impact factor: 5.594

Review 3.  [Spontaneous intracranial hypotension and Marfan syndrome].

Authors:  A Apetroae; T Strenzke; A Ferbert; P D Schellinger
Journal:  Nervenarzt       Date:  2016-08       Impact factor: 1.214

Review 4.  Pathophysiology and Pathogenesis of Marfan Syndrome.

Authors:  Sanford M Zeigler; Brandon Sloan; Jeffrey A Jones
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Endovascular treatment of genetically linked aortic diseases.

Authors:  D Böckler; K Meisenbacher; A S Peters; C Grond-Ginsbach; M S Bischoff
Journal:  Gefasschirurgie       Date:  2017-01-09

6.  Classification and Interpretation for 11 FBN1 Variants Responsible for Marfan Syndrome and Pre-implantation Genetic Testing (PGT) for Two Families Successfully Blocked Transmission of the Pathogenic Mutations.

Authors:  Songchang Chen; Hongjun Fei; Junyun Zhang; Yiyao Chen; Hefeng Huang; Daru Lu; Chenming Xu
Journal:  Front Mol Biosci       Date:  2021-12-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.